3
Announcements
Trials
Browse
Landscape
Status
No longer available
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
7
Observational
2
Expanded_access
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Lung Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Adenocarcinoma of Lung
1
Interventions
trilaciclib
1
taletrectinib
1
lazertinib
1
dabrafenib
1
capmatinib
1
brigatinib
1
belagenpumatucel L
1
Suspensions
1
Powders
1
Paclitaxel
1
BID protein, human
1
AMG 757
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Expanded_access
×
Lung Neoplasms
×
capmatinib
×
Clear all
NCT04741789
2026-03-16
Managed Access Programs for INC280, Capmatinib
Novartis
No longer available